Clinical trial

Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients

NCT00740532

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2007-10-01

PhaseN/A

Study timeline

Study start (unknown)2007-10-01Date precision: month

Registry last updated2010-09-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Gene mutation analyses and FISHGENETIC

Sponsors & collaborators

Istituto Clinico Humanitaslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00740532 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.